These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18248466)

  • 1. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
    Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
    Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
    Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
    Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
    Menaker GM; Chiang JK; Tabila B; Moy RL
    J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery for the treatment of malignant melanoma.
    Whalen J; Leone D
    Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostaining in Mohs micrographic surgery: a review.
    El Tal AK; Abrou AE; Stiff MA; Mehregan DA
    Dermatol Surg; 2010 Mar; 36(3):275-90. PubMed ID: 20100275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 2-hour method for rapid preparation of permanent paraffin sections when treating melanoma in situ with mohs micrographic surgery.
    Mallipeddi R; Stark J; Xie XJ; Matthews M; Taylor RS
    Dermatol Surg; 2008 Nov; 34(11):1520-6. PubMed ID: 18811716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 16-minute technique for evaluating melanoma resection margins during Mohs surgery.
    Chang KH; Finn DT; Lee D; Bhawan J; Dallal GE; Rogers GS
    J Am Acad Dermatol; 2011 Jan; 64(1):107-12. PubMed ID: 21167405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special stains in Mohs surgery.
    Miller CJ; Sobanko JF; Zhu X; Nunnciato T; Urban CR
    Dermatol Clin; 2011 Apr; 29(2):273-86, ix. PubMed ID: 21421151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
    Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
    Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control.
    Marra DE; Schanbacher CF; Torres A
    Dermatol Surg; 2004 May; 30(5):799-802. PubMed ID: 15099329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mohs surgery for melanoma: rationale, advances and possibilities.
    Etzkorn JR; Cherpelis BS; Glass LF
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1041-52. PubMed ID: 21806328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mohs micrographic surgery for the treatment of melanoma.
    Hui AM; Jacobson M; Markowitz O; Brooks NA; Siegel DM
    Dermatol Clin; 2012 Jul; 30(3):503-15. PubMed ID: 22800554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain.
    Hendi A; Brodland DG; Zitelli JA
    Arch Dermatol; 2006 Jul; 142(7):871-6. PubMed ID: 16847203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining melanoma frozen sections: the 1-hour protocol.
    Bricca GM; Brodland DG; Zitelli JA
    Dermatol Surg; 2004 Mar; 30(3):403-8. PubMed ID: 15008870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress of immunostains in Mohs micrographic surgery: a review.
    Thosani MK; Marghoob A; Chen CS
    Dermatol Surg; 2008 Dec; 34(12):1621-36. PubMed ID: 19018832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
    Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
    Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
    Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
    Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
    Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
    J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma Treated With Mohs Micrographic Surgery Using a Novel-Modified 15-Minute MART-1 Immunostain: Discussion of Technique and Experience.
    Cheraghi N; Demer A; Meister A; Lee P
    Dermatol Surg; 2021 Apr; 47(4):549-551. PubMed ID: 32483096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.